Overall, these results indicate that α-PD1 by itself and in combination with Ad19a/64-ERV ISDwt had only a modest effect on CT26 tumour control but showed remarkable synergistic effects when combined with the ISD modified vaccine, being able to eliminate most of the established CT26 tumours. This evidence concerns the gene DDX53 and neoplasm.